Observational Study of Triple Combination Therapy of Zemidapa Tab. and Metformin in Type 2 Diabetes Mellitus Patients

Trial to Evaluate the Efficacy on Glycemic Variability and Safety of Gemigliptin Compared With Dapagliflozin Added on Metformin Alone or Diabetes Medication Naïve Patient in Type 2 Diabetes Mellitus (Stable II Study)

NCT03202563 ·Status: COMPLETED ·Phase: PHASE4

Phase III Trial to Evaluate the Efficacy and Safety of Gemigliptin 50mg qd Added to Ongoing Glimepiride as Fix-dose Combination in Patients With Type 2 Diabetes

NCT02089126 ·Status: UNKNOWN ·Phase: PHASE3

Food-effect Bioavailability of Fixed Dose Combination Zemimet® SR Tab. 50/1000 mg Under Fed and Fasting Conditions

NCT04070794 ·Status: UNKNOWN ·Phase: PHASE1

Bioequivalence Study for Gemigliptin/Metformin 50/1000 mg and Coadministration of Gemigliptin 50 mg and Metformin 1000 mg.

NCT04050098 ·Status: UNKNOWN ·Phase: PHASE1

Study of the Durability of Glycemic Control With Nateglinide

NCT00858013 ·Status: COMPLETED ·Phase: PHASE4

Bioequivalence Study for Fixed Dose Combination Zemimet® SR Tab. 50/1000 and Coadministration of Gemigliptin 50 mg and Metformin 1000 mg.

NCT04317703 ·Status: COMPLETED ·Phase: PHASE1

Efficacy and Safety Comparison of Metformin/Glimepiride Combination Versus Each Compound Alone in New Diagnosed Type 2 Diabetes Patients

NCT01459809 ·Status: COMPLETED ·Phase: PHASE3

A Clinical Study to See How the Body Handles and How Safe a Combination Tablet of Gemigliptin, Dapagliflozin, and Metformin 50/10/1000mg is Compared to Taking Gemigliptin 50mg Separately With Dapagliflozin/Metformin 10/1000mg in Healthy Adults After a Meal

NCT07333742 ·Status: COMPLETED ·Phase: PHASE1

Metformin/Rosuvastatin Combination Therapy With in Patients With Type 2 Diabetes and Dyslipidemia

NCT02827903 ·Status: COMPLETED ·Phase: PHASE3

Clinical Trial to Compare the PK of the Fixed-dose Combinations and Each Component of Gemigliptin/Dapagliflozin 50/10 mg

NCT04544319 ·Status: UNKNOWN ·Phase: PHASE1

An Observational Study to Evaluate Cardiovascular Outcomes of T2DM PatientsTreated With Gemigliptin

NCT02290301 ·Status: COMPLETED

A Pharmacokinetic Study to Compare Co-administration of Repaglinide and Metformin HCl to Administration of Combination Preparation of Those Two Components

NCT01780051 ·Status: COMPLETED ·Phase: PHASE1

BE Study of the Combinations of Gemigliptin 50mg and Metformin HCl Extended Release 500mg in Comparison to Each Component Administered Alone

NCT01595880 ·Status: COMPLETED ·Phase: PHASE1

Trial to Evaluate the Efficacy and Safety of Gemigliptin Compared With Placebo Added on Insulin Alone or on Insulin in Combination With Metformin in Type 2 DM (ZEUS II Study)

NCT02831361 ·Status: COMPLETED ·Phase: PHASE3

A Open-label, Single-dose, 2-Sequence, 2-Period, Crossover Study to Assess Safety and Pharmacokinetics of a Nateglinide/Metformin HCl Combined Tablet Compared With a Nateglinide 120 mg Tablet and Metformin HCl 500 mg Tablet Under Fasting Conditions in Healthy Male Subjects

NCT02088918 ·Status: COMPLETED ·Phase: PHASE1

BE Study of the Combinations of Gemigliptin 50mg and Metformin HCl Extended Release 2000mg in Comparison to Each Component Administered Alone

NCT02670018 ·Status: UNKNOWN ·Phase: PHASE1

A Study to Evaluate the Efficacy and Safety of Dual add-on Therapy With Gemigliptin 50 mg and Dapagliflozin 10 mg Added to Metformin Who Have Inadequate Glycemic Control on Metformin Alone

NCT04255238 ·Status: UNKNOWN ·Phase: PHASE3

Study of Metabolic and Haemodynamic Effects of Metformin and Glimepiride in Patients With Type 2 Diabetes Mellitus

NCT01509001 ·Status: COMPLETED ·Phase: PHASE4

A Study Comparing the Amount of Metformin and After Taking a Combination Tablet vs. Separate Tablets

NCT01055691 ·Status: COMPLETED ·Phase: PHASE1

A Study in Type 2 Diabetic Subjects on Stable Metformin Therapy to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Co-administering Single and Multiple Oral Doses of GSK1292263

NCT01128621 ·Status: COMPLETED ·Phase: PHASE2

Initial Combination of Gemigliptin and Metformin on Microbiota Change

NCT02609815 ·Status: COMPLETED ·Phase: NA

Comparison of Biphasic Insulin Aspart 70/30, 50/50, and 30/70 in Subjects With Type 2 Diabetes

NCT00184574 ·Status: COMPLETED ·Phase: PHASE3

BE Study of the Combinations of Gemigliptin/Metformin HCl Extended Release 50/1000mg(25/500mg x 2 Tablets) in Comparison to Each Component Administered Alone

NCT03355014 ·Status: COMPLETED ·Phase: PHASE1

Effect of Gemigliptin on Metabolic Endotoxemia and Lipemia

NCT02186080 ·Status: COMPLETED ·Phase: NA

Efficacy and Safety of Biphasic Insulin Aspart 30 in Combination With Metformin in Type 2 Diabetes

NCT00619697 ·Status: COMPLETED ·Phase: PHASE4